Proteon Therapeutics Inc (PRTO): Flynn’s Purchasing Race
James E. Flynn, a large shareholder at Proteon Therapeutics Inc (NASDAQ:PRTO) disclosed today the acquisition…
Browsing: James E. Flynn
Ra Capital Management Considerably Surges Stake in Dyax Corp. (DYAX)
Peter Kolchinsky’s Ra Capital Management considerably boosted its stake in Dyax Corp. (NASDAQ:DYAX), a recent 13G filing…